The biosynthesis of the pyrrolyl moiety of the fungal metabolite rumbrin originates from pyrrole-2-carboxylic acid. In an effort to produce novel derivatives with enhanced biological activity a series of substituted pyrrole-2-carboxylates were synthesised and incubated with the producing organism, Auxarthron umbrinum. Several 4-halo-pyrrole-2-carboxylic acids were incorporated into the metabolite yielding three new derivatives: 3-fluoro-, 3-chloro-and 3-bromo-isorumbrin, which were generated in 10 milligram quantities enabling cytotoxicity assays to be conducted. The 3-chloro-and 3-bromoisorumbrins had improved activity against HeLa cells compared with rumbrin; 3-bromoisorumbrin also showed dramatically improved activity towards a lung cancer cell line (A549).
Introduction
Rumbrin (1) is a polyenyl pyrrole produced by a number of fungi 15 from the Onygenales family.
1,2 Naturally-occurring polyenylpyrroles are very rare, limited to a handful of examples, including the fungus-derived auxarconjugatins, 3 wallemias, 4 and malbranchpyrroles, 5 in addition to the keronopsins, brominated metabolites isolated from the marine ciliate Pseudokeronopsis The biological activity of 1 is of particular interest; it has been reported to possess cytoprotective activity, 1 and also acts as a calcium accumulation inhibitory agent and lipid peroxide 25 production inhibitor. 7 An isomer of rumbrin, (12E)-isorumbrin (1a), displays nanomolar activity as a cytotoxic agent, showing particular activity against lung and ovarian cancer cell lines. 8 The related polyenes auxarconjugatins A and B, which contain a chloropyrrole-group, have also been reported to possess 30 cytotoxic properties, 9 while in contrast, the furan-containing gymnoconjugatins possessed no significant activity. 8 Another group of pyrrolepolyenes, the malbrachpyrroles, were also found to possess cytotoxic properties against a range of cancer cell lines: it was suggested that they act by causing cell cycle arrest at 35 the G0/G1 phase. 5 Previous studies have produced a small number of unnatural rumbrin analogues. Supplementation of the growth medium of a rumbrin-producing strain Gymnoascus reessii with sodium bromide led to the production of a brominated analogue, in 40 addition to the non-halogenated derivative dechlororumbrin (2), though both compounds possessed much reduced cytotoxicity. 10 In 2010, Fang and coworkers reported the synthetic production of rumbrin and a range of derivatives. 9 One of these analogues (17-demethyl, 17-butyl-rumbrin) possessed nanomolar activity 45 against a lung cancer cell line (A549). Derivatives incorporating phenyl or thiophene rings in place of the terminal chloropyrrole group displayed no activity. Thus, the available evidence from both natural and modified pyrrolylpolyenes suggests a crucial role for the chloropyrrole moiety in their biological activity. 50 The biosynthesis of rumbrin has been investigated using feeding studies with isotopically labelled substrates. These studies revealed that rumbrin is biosynthesised from proline, methionine, and acetate (Scheme 1). 11 Intriguingly, it was also found that pyrrole-2-carboxylic acid is a direct precursor in the 55 biosynthesis of rumbrin, and that the un-natural precursor 4-chloro-pyrrole-2-carboxylate can be successfully incorporated to form 3-chloroisorumbrin (3). Though the modified polyene was not isolated in this instance, this observation opened the possibility of producing additional rumbrin derivatives through 60 precursor-directed biosynthesis.
In the current study we have followed up on these findings, carrying out precursor-director biosynthesis with a range of substituted pyrrole-2-carboxylic acids. We report the production, characterisation and biological properties of three rumbrin derivatives: 3-chloroisorumbrin (3), 3-bromoisorumbrin (4) and 3-fluoroisorumbrin (5). 
Results and Discussion
A small suite of substituted pyrrole-2-carboxylates (6-17) was used in the study. Acetyl-, chloro-, bromo-, and iodo-pyrrole 10 carboxylic acids were synthesised from trichloroacetylpyrrole or pyrrole carboxylate methyl ester using electrophilic substitution strategies. 12 While 4-iodo-pyrrole carboxylic acid (10) was formed in quantitative yield, the other substitution reactions produced mixtures of 4-, 5-, and/or di-substituted pyrrole 15 carboxylic acids. Attempts to produce fluorinated pyrrole-2-carboxylic acids by direct fluorination of trichloroacetylpyrrole using a range of fluorinating agents gave poor yields. Thus, alternative literature syntheses were used to produce pyrroles 9 and 16 instead. The commercially available strain Auxarthron umbrinum DSM-3193 was used in precursor-directed biosynthesis experiments, and grown using a rich cottonseed-flour based medium.
11 Precursors (3 mM) were introduced to the fungal 25 culture after three days, immediately prior to the commencement of polyene biosynthesis. After seven days the cultures (25 mL) were filtered, the mycelium extracted with MeOH-CH 2 Cl 2 (3:1), and the extracts analysed by electrospray mass spectrometry (ESI(+)MS) and HPLC to determine whether new polyenes had 30 been produced. Altered HPLC profiles (Fig 1) were observed when the growth medium was supplemented with 4-chloro-, 4-bromo-, and 4-fluoro-pyrrole-2-carboxylates (7-9). In the latter two cases, new peaks were also observed in the mass spectrum, at m/z 402/404, and 342, respectively, suggesting successful production of the target polyenes. Pyrrole-carboxylates with 40 larger substituents in the 4-position, 10-12, were not accepted as the biosynthetic starter unit, nor were the 5-substituted (13, 14) or di-substituted (15) (16) (17) acids. Supplementing the growth medium with pyrrole-2-carboxylic acid (6) led to an increased production of non-halogenated polyenes such as dechlororumbrin (2), as 45 reported previously.
11
Syntheses of the successfully incorporated precursor pyrroles 7-9 were conducted on a larger scale (100-200 mg), and the feeding studies repeated using 8 x 25 mL cultures for each experiment. The fungal mycelia were extracted as before and the presence of bromine substitution at C-3, were sufficient to unambiguously confirm the structure as shown. 3 Hz, C-4) also displayed splitting due to proximity to fluorine. These data were all consistent with the proposed structure. 15 Compounds 1a, 3-5 were tested for cytotoxic activity against a range of cancer cell lines (Table 2 ) using an MTT colourimetric assay. 15 These showed promising results, with 1a, 3, and 4 showing nanomolar activity against a cervical cancer cell line (HeLa), with 4 displaying the highest activity (35 nM). This 20 compound also displayed nanomolar activity against a lung cancer line (A549). Compounds 1a, 3 and 4 displayed low levels of activity against a non-neoplastic control line (HDF). In contrast, the fluorinated derivative 5 exhibited much reduced activity against HeLa cells but moderate activity against the other 25 three cell lines tested.
Conclusions
Precursor-directed biosynthesis is a convenient way to introduce new atoms or groups into known natural products, in particular 30 halogens, which can impact on the biological activity of the compound in question 16 or provide a functionalizable handle for further modification. 17 These findings are of great interest as they show that the 3-chloropyrrole moiety is not absolutely essential for biological activity in this class of polyenes. In 35 addition, the differences in selectivity displayed by the various derivatives, show that rumbrin derivatives may have potential as clinical anticancer agents, and that their potency and selectivity may be tuned by synthetic or biosynthetic manipulation of the pyrrole moiety. 
Experimental

45
Auxarthron umbrinum DSM-3193 was obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ). All media components were purchased from Sigma-Aldrich and Oxoid. 4-nitro-pyrrole-2-carboxylic acid (12) was purchased from Fluorochem. The fluorinated pyrroles 9 and 16 were 50 synthesised according to literature procedures. 13, 14, 18 All other chemicals were purchased from Sigma-Aldrich and AGB, except as otherwise specified. All solvents were HPLC grade and used without further purification.
HPLC was carried out using a Varian Prostar system consisting of two solvent delivery modules (210), diode array detector (335), autoinjector (410) and fraction collector (710). A Zorbax StableBond C-18 column, 9.4 x 250 mm, 5 µm particle 5 size, was used in all preparative HPLC separations. NMR was conducted using Varian Inova 300, 400, and 500 MHz spectrometers, and referenced to residual signals in the solvent (for DMSO, δ H 2.50 and δ C 39.5 ppm), and CFCl 3 for 19 F. UV-vis spectra were recorded on a Thermo-Spectronic Helios-β 10 spectrophotometer. Low resolution mass spectra were obtained using a Micromass Quattro mass spectrometer, and high resolution spectra on a Micromass LCT time-of-flight mass spectrometer, both coupled to a Waters Alliance 2695 solvent delivery system. Chloropyrrole-2-carboxylic acids (7, 15) 12, 19 Trichloroacetylpyrrole (213 mg, 1 mmol) was dissolved in CHCl 3 (5 mL), and cooled on ice. SO 2 Cl 2 (84 µL, 1 mmol) was added 50 dropwise with stirring. Additional aliquots of SO 2 Cl 2 were added until no starting material remained. The solution was warmed to room temperature over an hour. The reaction mixture was quenched by adding ice, extracted with 50 mM Na 2 HPO 4 (pH 7.0) until neutral, and the organic phase reduced to dryness under 55 vacuum. The solid residue was dissolved in 2 M NaOH (10 mL) and stirred for 30 min at room temperature. The aqueous solution was acidified to pH 1, extracted with Et 2 O (2 × 20 mL), and the organic extracts reduced to dryness. 
4-Iodopyrrole-2-carboxylic acid (10)
12, 21
Iodine (120 mg, 0.47 mmol) was added in small portions to stirred solution of trichloroacetylpyrrole (110 mg, 0.52 mmol) and AgNO 3 (85 mg, 0.50 mmol) in CHCl 3 (5 mL) at 0 ˚C. The 100 reaction mixture was allowed to warm to room termperature and stirred for a further 2 h. The suspension was then filtered, washed with Na 2 SO 3 solution (5 mL, 5%) and water (5 mL, x 2), dried over MgSO 4 , and concentrated under nitrogen. The residue was suspended in DMSO (0.5 mL) and K 2 CO 3 (2 M, 1.5 mL) added 105 dropwise. The mixture was stirred at room temperature for 3 h. This was then acidified with HCl, extracted with EtOAc (5 mL x 3), the organic layer dried over MgSO 4 , and reduced to dryness under vacuum to yield 10 (123 mg, 100 %). Acetylpyrrole-2-carboxylic acids (11, 14) 
3-Chloroisorumbrin (3)
Eight flasks were used in the feeding experiment, using conditions as detailed above. After three days, 4-chloro-pyrrole-2-carboxylic acid (7, 20 
3-Bromoisorumbrin (4)
Eight flasks were used in the feeding experiment, using conditions as detailed above. After three days, 4-bromo-pyrrole-2-carboxylic acid (8, 15 
3-Fluoroisorumbrin (5)
90
Eight flasks were used in the feeding experiment, using conditions as detailed above. After three days, 4-fluoro-pyrrole-2-carboxylic acid (9, 15 mg/flask, 4.7 mM) was added to each flask. The mycelium from all flasks was combined and extracted twice with MeOH-CH 2 Cl 2 (1:1) for one hour. The organic extract 95 was reduced under vacuum, and partitioned between water-CH 2 Cl 2 , and the organic fraction reduced under vacuum and repartitioned between hexane and methanol. The methanolic fraction was reduced under vacuum and fractionated by solidphase extraction (Thermo-Fisher Hypersep C 18 
